GlassScriptPhysician profile
William A Clark
NPI 1982605739
$1,731.62
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,333 · 2022: $381 · 2023: $17.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $257.84 | 2021-2022 | |
| Novo Nordisk INC | $229.53 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $204.77 | 2021 | |
| Amgen INC. | $185.81 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $101.57 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $72.34 | 2021 | |
| Pfizer INC. | $69.52 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $63.29 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $54.56 | 2021-2022 | |
| Lundbeck LLC | $49.06 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.38 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $40.29 | 2021 | |
| Phadia US INC. | $35.77 | 2021 | |
| Amarin Pharma, INC. | $33.90 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.70 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $26.13 | 2021 | |
| Glaxosmithkline, LLC. | $24.36 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.91 | 2022 | |
| Fidia Pharma USA INC. | $18.51 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $17.73 | 2022 | |
| Boston Scientific Corporation | $17.62 | 2023 | |
| Merck Sharp & Dohme LLC | $17.19 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.95 | 2022 | |
| Adlon Therapeutics L.P. | $15.53 | 2021 | |
| Abbott Laboratories | $15.38 | 2022 | |
| Lilly USA, LLC | $14.79 | 2022 | |
| Grt US Holding, INC. | $13.78 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.21 | 2021 | |
| Antares Pharma, INC. | $12.34 | 2022 | |
| Dynavax Technologies Corporation | $8.86 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.